Company intelligence / Profile preview

Orthocon

Irvington, New York, USAlinkedin.com ↗

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

Orthocon developed absorbable surgical products designed to stop bone bleeding and deliver drugs locally during orthopedic and spine surgeries. Its lead product, Hemasorb Absorbable Bone Hemostat Matrix, received FDA 510(k) clearance in 2011. The company also developed proprietary applicators like "Hemasorb Apply." Clinical results were not detailed publicly but the company advanced to commercial stage with its first product by 2011. No recent clinical or commercial updates have been reported since then.

Therapeutic areas: OtherHematology
Modalities: DeviceHydrogel-based drug delivery therapySmall molecule
Industry: Surgical Medical Devices

Drug pipeline

2 assets

HEMASORB

Commercial

Indications: Bone bleeding

1 more asset in the full pipeline.

Request access →

Partnerships

Bezwada Biomedical – exclusive worldwide license agreement for bioabsorable polyurethane/polyamide technology used in surgical devices

Beyond the preview

Go deeper on Orthocon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthocon.

Explore the full profile